Ultima Genomics' UG200 Series Chosen for Basecamp Research's Trillion Gene Atlas
Event summary
- Basecamp Research selected Ultima Genomics' UG200 Series for its Trillion Gene Atlas initiative, aiming to collect genomic data from over 100 million new species.
- The collaboration aims to expand evolutionary genetic diversity by 100x, addressing the industry's 'data wall' in AI drug development.
- Basecamp Research's EDEN foundation models will train on BaseData™, a proprietary genomic database over 10 times larger than all public resources combined.
- Ultima Genomics' wafer-based sequencing architecture enables ultra-high-throughput sequencing at extremely low cost.
- The Trillion Gene Atlas is the latest large-scale data generation project utilizing Ultima's technology, following initiatives like the Virtual Cell Initiative and the Billion Cell Project.
The big picture
The selection of Ultima Genomics' UG200 Series for the Trillion Gene Atlas underscores the growing need for large-scale genomic data in AI-driven drug development. This collaboration highlights the strategic shift towards leveraging evolutionary diversity to build better medicines, addressing the industry's data constraints. The initiative is part of a broader trend of integrating high-throughput sequencing with advanced AI models to catalyze the next phase of genomics.
What we're watching
- Data Scale Impact
- How the 100-fold expansion of genomic data will affect AI drug development and the pace of breakthroughs in therapeutic design.
- Technological Integration
- Whether Ultima Genomics' sequencing technology can sustain the massive data generation required for the Trillion Gene Atlas and similar initiatives.
- Industry Collaboration
- The extent to which partnerships with Anthropic, NVIDIA, and PacBio will drive advancements in biological data generation and AI model development.
Related topics